Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research-Reference-Cited by-同舟云学术

Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research

Published:2023-03 Issue:3 Volume:29 Page:151-163
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Schoettler M.L.,Carreras E.,Cho B.^ORCID,Dandoy C.E.,Ho V.T.,Jodele S.,Moissev I.,Sanchez-Ortega I.,Srivastava A.^ORCID,Atsuta Y.^ORCID,Carpenter P.,Koreth J.,Kroger N.,Ljungman P.^ORCID,Page K.^ORCID,Popat U.,Shaw BE.,Sureda A.,Soiffer R.,Vasu S.

Funder

American Society for Blood and Marrow Transplantation

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference79 articles.

1. Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management;Dvorak;Front Pediatr,2019

2. Pretransplant genetic susceptibility: clinical relevance in transplant-associated thrombotic microangiopathy;Gavriilaki;Thromb Haemost,2020

3. The genetic fingerprint of susceptibility for transplant associated thrombotic microangiopathy;Jodele;Blood,2016

4. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis;Young;Bone Marrow Transplant,2021

5. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury;Jodele;Blood Rev,2015

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy;Transplantation and Cellular Therapy;2024-09

2. Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children;Transplantation and Cellular Therapy;2024-09

3. Application of the Consensus Definition of Transplant Associated Thrombotic Microangiopathy (TA-TMA) Requires a More Expansive Lens to Accurately Diagnose and Risk Stratify Patients—Beware Reliance on Schistocytes Alone;Transplantation and Cellular Therapy;2024-08

4. Real-world analysis of the underdiagnosis, clinical outcomes and associated burden of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in the United States;Frontiers in Hematology;2024-07-15

5. Hemostasis and complement in allogeneic hematopoietic stem cell transplantation: clinical significance of two interactive systems;Bone Marrow Transplantation;2024-07-14